Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants.
Mazzola TN, da Silva MT, Abramczuk BM, Moreno YM, Lima SC, Zorzeto TQ, Passeto AS, Vilela MM.
AIDS. 2011 Nov 13;25(17):2079-87.
Related citations
[Relationship between precariousness, social coverage, and vaccine coverage: survey among children consulting in pediatric emergency departments in France].
Bouhamam N, Laporte R, Boutin A, Uters M, Bremond V, Noel G, Rodier P, Minodier P.
Arch Pediatr. 2012 Mar;19(3):242-7. Epub 2012 Jan 4. French.
A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.
Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR.
Clin Infect Dis. 2012 Apr;54(7):938-45. Epub 2012 Jan 11.
Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5.
Lorenzo MM, Sánchez-Puig JM, Blasco R.
J Gen Virol. 2012 Apr;93(Pt 4):733-43. Epub 2012 Jan 13.
Flavivirus-induced antibody cross-reactivity.
Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, Galbraith SE, Solomon T, Fooks AR.
J Gen Virol. 2011 Dec;92(Pt 12):2821-9. Epub 2011 Sep 7.
Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques.
Takeuchi K, Nagata N, Kato SI, Ami Y, Suzaki Y, Suzuki T, Sato Y, Tsunetsugu-Yokota Y, Mori K, Van Nguyen N, Kimura H, Nagata K.
J Virol. 2012 Mar;86(6):3027-37. Epub 2012 Jan 11.
Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.
Li J, Ertel A, Portocarrero C, Barkhouse DA, Dietzschold B, Hooper DC, Faber M.
J Virol. 2012 Mar;86(6):3200-10. Epub 2012 Jan 11.
Haiti prepares for cholera vaccination but concerns remain.
Adams P.
Lancet. 2012 Jan 7;379(9810):16. No abstract available. Erratum in: Lancet. 2012 Mar 24;379(9821):1102.
The new decade of vaccines.
Hachey K.
Lancet. 2012 Jan 7;379(9810):27. No abstract available.
Shann F.
Lancet. 2012 Jan 7;379(9810):26; author reply 27. No abstract available.
Aaby P, Martins C, Benn CS, Whittle H.
Lancet. 2012 Jan 7;379(9810):25-6; author reply 27. No abstract available.
Increased transmission and outbreaks of measles--European Region, 2011.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1605-10.
The value of HPV vaccination.
[No authors listed]
Nat Med. 2012 Jan 6;18(1):28-9. doi: 10.1038/nm0112-28. No abstract available.
Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
Vesikari T, Prymula R, Schuster V, Tejedor JC, Cohen R, Bouckenooghe A, Damaso S, Han HH.
Pediatr Infect Dis J. 2012 May;31(5):509-13.
Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.
Ellison AM, Ota KV, McGowan KL, Smith-Whitley K.
Pediatr Infect Dis J. 2012 May;31(5):534-6.
Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
Omenaca F, Sarlangue J, Szenborn L, Nogueira M, Suryakiran PV, Smolenov IV, Han HH; ROTA-054 Study Group.
Pediatr Infect Dis J. 2012 May;31(5):487-93.
Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata.
Skowronski DM, Hottes TS, De Serres G, Ward BJ, Janjua NZ, Sabaiduc S, Chan T, Petric M.
Pediatr Infect Dis J. 2011 Oct;30(10):833-9.
The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R.
Pediatrics. 2012 Feb;129(2):248-55. Epub 2012 Jan 9.
Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis.
Haghi F, Peerayeh SN, Siadat SD, Zeighami H.
Vaccine. 2012 Feb 21;30(9):1710-4. Epub 2012 Jan 9.
Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.
Goicochea MA, Zapata JC, Bryant J, Davis H, Salvato MS, Lukashevich IS.
Vaccine. 2012 Feb 14;30(8):1445-52. Epub 2012 Jan 9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on